Fluorine-18-ML-10

N/A

Report date: 2025/12/01 17:17:00
NME

Base Information

Drug NameFluorine-18-ML-10
Drug Alias NameF-18-ML-10[18F]-ML-10ML-10
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionDiagnostic imaging enhancers
TargetsUpdating
Therapy Area/IndicationsBrain metastasesSolid tumoursCarcinoma, Non-Small-Cell Lung +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAposense Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcAposense Ltd
Active IndicationsN/A
Inactive IndicationsBrain metastasesSolid tumoursCarcinoma, Non-Small-Cell Lung +[5] 

Other Information

ATC CodeN/A
Related LinksN/A